Sonova updates sustainability-linked financing, shares on SIX in focus
25.06.2026 - 14:05:30 | ad-hoc-news.de
By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 14:04.
Sonova Holding AG (CH0012549785) has refreshed information on its sustainability-linked financing, including a second-party opinion from ISS ESG, underscoring its ESG positioning alongside its core hearing-care business. The Switzerland-based group continues to trade on SIX Swiss Exchange, drawing interest from investors following European medtech names.
New details on sustainability-linked financing
According to Sonova's updated sustainability-linked financing section, the company uses a Sustainability-Linked Financing Framework to align funding costs with environmental and social targets, backed by a second-party opinion from ISS ESG as framework reviewer. The company explains the framework and reviewer role on its ESG-focused investor page.
Sonova states that the framework enables instruments such as sustainability-linked bonds and loans tied to pre-defined key performance indicators, covering areas like CO2 reduction and social impact. The documentation links the group's financing strategy to goals laid out in its annual Sustainability Report and broader capital-market communication.
Earnings calendar, analyst consensus and SIX listing
On its investor-relations site Sonova highlights its financial calendar, including annual general meetings and results dates, while detailed upcoming earnings dates for the current fiscal year remain concentrated around the customary late spring and autumn reporting windows. The financial calendar groups events such as full-year results presentations and AGMs.
Analyst coverage compiled on platforms such as MarketScreener shows a majority of brokers with Buy or equivalent ratings on Sonova, reflecting a generally constructive stance on the hearing-care sector and peers like Demant and Amplifon. The stock is traded on SIX Swiss Exchange under the ticker SOON, providing investors with exposure to a global leader in hearing instruments and cochlear implants in a European medtech context.
All news and analysis on the Sonova Holding AG shares
Stay on top of Sonova's earnings dates, ESG financing developments and analyst views with the full coverage on ad-hoc-news.de and the company's investor-relations pages.
The product behind the stock
One of Sonova's flagship offerings is the Phonak Audeo Lumity receiver-in-canal hearing aid line, which focuses on improving speech understanding in challenging listening environments through advanced signal processing. The product family complements Sonova's portfolio in audiological care and implants.
Where the stock trades today
As of 2026-06-25, 12:00, Sonova shares last traded at 270.50 CHF on SIX Swiss Exchange.
Sonova Holding AG at a glance
- Company: Sonova Holding AG
- ISIN: CH0012549785
- WKN: 125497
- Ticker: SOON
- Trading venue: SIX Swiss Exchange
- Price (as of 2026-06-25, 12:00): 270.50 CHF
- Market cap: 16.8 billion CHF (as of 2026-06-25)
- Sector / industry: Health Care - Medical Devices
- Index membership: SMI
- Next earnings date: 2026-11-18
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
